Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy
S. Yamachika1, J. Brayer1, G.E. Oxford1, A.B. Peck3,4, M.G. Humphreys-Beher1,3
1Department of Oral Biology, 2Department of Pathology and Laboratory Science, and the 3Center for Orphaned Autoimmune Disease, University of Florida, Gainesville, Florida, USA.
ABSTRACT
Objective
The protein components of the extracellular matrix (ECM)
are responsible for driving tissue morphogenesis, the development
of differentiated function, and the sequestration of biologically
active molecules such as growth factors in close proximity to
tissue and organ cells. Recent reports indicate that saliva and
exocrine tissue lysates from Sjögren's syndrome patients and the
non-obese diabetic (NOD) mouse model for autoimmune exocrinopathy
demonstrate elevated levels of specific enzymes that degrade the
ECM, especially the matrix metalloproteinases (MMPs). To
determine if elevated levels of MMPs could be important in
exocrine tissue destruction, we examined proteolytic activity
against two ECM proteoglycans, decorin and biglycan.
Methods
Purified recombinant human core protein for decorin or
biglycan was incubated with saliva or gland lysates from either
control BALB/c or NOD mice. Degraded proteoglycan products were
estimated by Western blotting analysis using anti-decorin or
anti-biglycan monospecific polyclonal antibodies. The levels of TGFb protein were measured by ELISA.
Results
Proteolytic activity for decorin and biglycan was not
observed in the saliva and salivary gland lysates collected from
C57BL/6 or BALB/c mice used as normal controls. In contrast, both
proteoglycans were degraded by saliva and exocrine gland lysates
from NOD mice and the congenic partner strains NOD-scid and NOD.B10.H2b. This proteolytic activity for proteoglycans was
inhibited by the MMP inhibitors, EDTA, GM6001 and
1,10-phenanthroline. Protein steady state levels for TGFb were
increased in the saliva and gland lysates from 20-week old NOD
strains, as compared to BALB/c mice and NOD treated with the MMP
inhibitor GM6001. With the inhibition of MMP activity, TGFb
levels declined in saliva and gland lysates.
Conclusion
Proteolytic degradation of the ECM molecules decorin and
biglycan is elevated in the exocrine tissues of the NOD mouse
model for Sjögren's syndrome. Furthermore, the proteolysis of
small leucine-rich proteoglycans correlates with the presence of
elevated levels of TGFb in gland lysates and saliva.
Key words
Extracellular matrix proteins, Sjögren's syndrome,
proteases, exocrine glands.
This work was supported by NIH/NIDR grant DE 10515 and by an administrative supplement from the Office for Research in Women's Health Policy to Dr. Humphreys-Beher. Dr. Peck was supported by a Juvenile Diabetes Foundation International grant (I96091). Mr. Brayer and Dr. Oxford were supported by NIDR training grant DE 00072.
Please address correspondence and reprint requests to: Dr.
Michael G. Humphreys-Beher, Department of Oral Biology, P.O. Box 100424, University of Florida, Gainesville, FL 32610,
USA.
E-mail: h-beher@dental.ufl.edu
Clin Exp Rheumatol 2000; 18: 233-240.
© Copyright Clinical and
Experimental Rheumatology
2000.